Target intelligence / Profile preview

RNA, U6 small nuclear 620, pseudogene (RNU6-620P)

Target
RNU6-620P
Molecular classification
Other (Pseudogene)
01

Overview

RNA, U6 small nuclear 620, pseudogene (RNU6-620P) is classified as a pseudogene of U6 small nuclear RNA (U6 snRNA). U6 snRNA is a non-coding RNA component integral to the spliceosome, involved in the removal of introns from pre-messenger RNA through splicing[1][3]. However, pseudogenes such as RNU6-620P generally lack the ability to code for functional RNA or protein products due to accumulated mutations or the lack of necessary regulatory elements[2]. There is no evidence that RNU6-620P has a direct biological function, disease association, or pharmacological relevance, and it is not recognized as a therapeutic target. It is considered a product of genomic duplication or retrotransposition, serving primarily as a genomic fossil without recognized function[2]. This entry does not describe a true therapeutic target such as a receptor, enzyme, or transporter. As a pseudogene, it lacks druggability, functional relevance in cell signaling, or direct disease roles based on current scientific knowledge. Therefore, it should not be treated as a valid molecular therapeutic target[2].

Other names
RNU6-620PRNA, U6 small nuclear 620, pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 620, pseudogene (RNU6-620P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 620, pseudogene (RNU6-620P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call